Research News
Alendronate may cut hip fracture risk in older patients taking prednisolone
BMJ 2017; 358 doi: https://doi.org/10.1136/bmj.j3348 (Published 11 July 2017) Cite this as: BMJ 2017;358:j3348- Jacqui Wise
- London
Older patients who take the anti-inflammatory steroid prednisolone would benefit from treatment with the osteoporosis drug alendronate because it reduces the risk of hip fracture, a retrospective cohort study published in JAMA has found.1
Glucocorticoid therapy is widely used to treat inflammatory conditions and is commonly prescribed for patients over 65. However, it can lead to rapid bone loss and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.